Sixth Annual Head and Neck Cancer Symposium Evaluation

As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice

	5	4	3	2	1	N/A
Summarize the distribution and determinants of recent data which includes trends and projections to assist with screening and prevention.	Summarize the distribution and determinants of recent data which includes trends and projections to assist with screening and prevention. - 5	Summarize the distribution and determinants of recent data which includes trends and projections to assist with screening and prevention. - 4	Summarize the distribution and determinants of recent data which includes trends and projections to assist with screening and prevention. - 3	Summarize the distribution and determinants of recent data which includes trends and projections to assist with screening and prevention. - 2	Summarize the distribution and determinants of recent data which includes trends and projections to assist with screening and prevention. - 1	Summarize the distribution and determinants of recent data which includes trends and projections to assist with screening and prevention. - N/A
Identify treatment modalities, prognosis and clinical management available to patients.	Identify treatment modalities, prognosis and clinical management available to patients. - 5	Identify treatment modalities, prognosis and clinical management available to patients. - 4	Identify treatment modalities, prognosis and clinical management available to patients. - 3	Identify treatment modalities, prognosis and clinical management available to patients. - 2	Identify treatment modalities, prognosis and clinical management available to patients. - 1	Identify treatment modalities, prognosis and clinical management available to patients. - N/A
Differentiate HPV positive and negative cancers.	Differentiate HPV positive and negative cancers. - 5	Differentiate HPV positive and negative cancers. - 4	Differentiate HPV positive and negative cancers. - 3	Differentiate HPV positive and negative cancers. - 2	Differentiate HPV positive and negative cancers. - 1	Differentiate HPV positive and negative cancers. - N/A

How effective were the following speakers in meeting their learning objectives? *

Scoring key: 5=Very effective, 4= Effective, 3= Somewhat effective, 2= Slightly effective, 1= Completely Ineffective Speakers are listed according to the lecture schedule.

	5	4	3	2	1	N/A
Epidemiology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D.	Epidemiology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D. - 5	Epidemiology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D. - 4	Epidemiology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D. - 3	Epidemiology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D. - 2	Epidemiology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D. - 1	Epidemiology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D. - N/A
Panel Discussion: Epidemiology of HPV-Positive Head and Neck Cancer	Panel Discussion: Epidemiology of HPV-Positive Head and Neck Cancer - 5	Panel Discussion: Epidemiology of HPV-Positive Head and Neck Cancer - 4	Panel Discussion: Epidemiology of HPV-Positive Head and Neck Cancer - 3	Panel Discussion: Epidemiology of HPV-Positive Head and Neck Cancer - 2	Panel Discussion: Epidemiology of HPV-Positive Head and Neck Cancer - 1	Panel Discussion: Epidemiology of HPV-Positive Head and Neck Cancer - N/A
Molecular Biology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D.	Molecular Biology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D. - 5	Molecular Biology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D. - 4	Molecular Biology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D. - 3	Molecular Biology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D. - 2	Molecular Biology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D. - 1	Molecular Biology of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph.D. - N/A
Panel Discussion: Diagnosis Challenges in HPV and Head and Neck Cancer	Panel Discussion: Diagnosis Challenges in HPV and Head and Neck Cancer - 5	Panel Discussion: Diagnosis Challenges in HPV and Head and Neck Cancer - 4	Panel Discussion: Diagnosis Challenges in HPV and Head and Neck Cancer - 3	Panel Discussion: Diagnosis Challenges in HPV and Head and Neck Cancer - 2	Panel Discussion: Diagnosis Challenges in HPV and Head and Neck Cancer - 1	Panel Discussion: Diagnosis Challenges in HPV and Head and Neck Cancer - N/A
Survival of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph. D.	Survival of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph. D. - 5	Survival of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph. D. - 4	Survival of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph. D. - 3	Survival of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph. D. - 2	Survival of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph. D. - 1	Survival of HPV-Positive Head and Neck Cancer - Maura L. Gillison, M.D., Ph. D. - N/A
Panel Discussion: Treatment of HPV and Head and Neck Cancer at Miami Cancer Institute	Panel Discussion: Treatment of HPV and Head and Neck Cancer at Miami Cancer Institute - 5	Panel Discussion: Treatment of HPV and Head and Neck Cancer at Miami Cancer Institute - 4	Panel Discussion: Treatment of HPV and Head and Neck Cancer at Miami Cancer Institute - 3	Panel Discussion: Treatment of HPV and Head and Neck Cancer at Miami Cancer Institute - 2	Panel Discussion: Treatment of HPV and Head and Neck Cancer at Miami Cancer Institute - 1	Panel Discussion: Treatment of HPV and Head and Neck Cancer at Miami Cancer Institute - N/A

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

How many patients will you see in your practice who will likely be impacted by what you learned at this activity? *

1-5

6-10

Over 10

Not applicable to my practice

Is this your first time attending this symposium? *

Yes

No

How did you hear about us? *

Would you attend this symposium again next year? *

Yes

No

If you checked "No,” please tell us why: *

Would you recommend this symposium to a colleague? *

If you checked "No,” please explain why you would not recommend this course: *

What do you intend to do differently in the treatment of your patients as a result of what you learned? What new strategies will you apply in your practice of patient care? *

If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so.

Suggested topics and/or speakers you would like for future symposiums.

Comments

Name

You are here

Sixth Annual Head and Neck Cancer Symposium Evaluation